Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
ID:
Password:
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

Agents/Distributors
 Regional Subscription Agents/Distributors
 
Current Trends in Endocrinology   Volumes    Volume 6 
Abstract
Klinefelter’s syndrome and cardiovascular disease
Daniela Esposito, Andrea Renzullo, Giacomo Accardo, Filomena Barbato, Andrea Salzano, Antonio Cittadini, Daniela Pasquali
Pages: 91 - 96
Number of pages: 6
Current Trends in Endocrinology
Volume 6 

Copyright © 2012 Research Trends. All rights reserved

ABSTRACT
 
Klinefelter’s syndrome (KS) is the most common sex-chromosome male disorder, characterized by one or more extra X chromosomes. It is associated with a significant increase of cardiovascular mortality and morbidity. This review examines cardiovascular (CV) abnormalities known in KS until now. KS is associated with both functional and structural CV alterations, particularly KS patients show a wide range of CV abnormalities, specifically LV diastolic dysfunction, impaired exercise performance, Chronotropic Incompetence (CI), and increased carotid intima-media thickness (IMT). Regarding diastolic function, they display an increased Isovolumetric Relaxation Time (IVRT) but no prolongation of Mitral deceleration Time (MdT). This condition indicates the presence of a mild diastolic dysfunction. KS patients also have an exercise intolerance, that depends on reduced stroke volume during exercise, caused by the limited increase in the LV end-diastolic volume despite normal ejection fraction and the increased LV filling pressure and left atrial pressure during exercise. Patients with KS also display a significant increase of carotid IMT, a surrogate marker of atherosclerotic disease. This alteration represents a subclinical marker of early atherosclerosis and is the most important risk factor of new or recurrent stroke and myocardial infarction. Testosterone replacement therapy does not normalize the impaired cardiovascular parameters. This wide range of CV abnormalities represents the pathophysiological underpinnings for the raised mortality observed in KS.

 

View Full Article  


 
search


E-Commerce
Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Login
Search Products
Browse in Alphabetical Order : Journals
Series/Books
Browse by Subject Classification : Journals
Series/Books

Miscellaneous
Ordering Information Ordering Information
Downloadable forms Downloadable Forms